CRI Voices:戊型肝炎疫苗来了(2)

英语自学网

2012021092620779_328_o11.jpg

■中国国际广播之声（CRI）是中国向全世界广播的国家广播之声。其宗旨是“向世界介绍中国，向中国介绍世界，向世界报道世界，增进中国人民与世界人民之间的了解和友谊”。
■本节目听写包罗万千，涉及经济，政治，科学，文化等，皆在提高沪友听力水平，增进知识，何乐而不为？
参与方式：全文听写
Hints:
the World Health Organization
South and East Asia
The Xiamen Innovax Biotech
Haicang District of Xiamen
Haicang District
Zhang Quan
bio-medicine

sub_411.gif

btn_listen1974111.gif

Last December, the vaccine was granted an official approval for medical production, and is expected to go into mass production this June. The ministry says China will vaccinate those deemed to be at high risk of becoming infected and will work with international organizations to introduce it to other countries.
According to the World Health Organization, one third of the global population is estimated to be infected by the virus and countries in South and East Asia report about 6.5 million cases of infection every year.
The Xiamen Innovax Biotech company, located in the Haicang District of Xiamen, has been given high priority in the development of the local biopharmaceutical industry. As deputy head of the Haicang District, Zhang Quan explains that their goal is to develop the region's biopharmaceutical industry into a large national base for bio-medicine with funds in place somewhere in the region of 200 million yuan.
"We are increasing our efforts for the construction of a special development area for biopharmaceutical enterprises. We shall continue to increase funds and the amount of technical assistance that will be offered to biopharmaceutical enterprises. We have a target in mind to build the district into a large, active, national level biopharmaceutical industrial base with a high level of professionalism.